Risk and predictive factors for severe dengue infection: A systematic review and meta-analysis

PLoS One. 2022 Apr 15;17(4):e0267186. doi: 10.1371/journal.pone.0267186. eCollection 2022.

Abstract

Background: Dengue is a major public health issue worldwide and severe dengue (SD) is life threatening. It is critical to triage patients with dengue infection in the early stage. However, there is limited knowledge on early indicators of SD. The objective of this study is to identify risk factors for the prognosis of SD and try to find out some potential predictive factors for SD from dengue fever (DF) in the early of infection.

Methods: The PubMed, Cochrane Library and Web of Science databases were searched for relevant studies from June 1999 to December 2020. The pooled odds ratio (OR) or standardized mean difference (SMD) with 95% confidence intervals (CI) of identified factors was calculated using a fixed or random effect model in the meta-analysis. Tests for heterogeneity, publication bias, subgroup analyses, meta-regression, and a sensitivity analysis were further performed.

Findings: A total of 6,848 candidate articles were retrieved, 87 studies with 35,184 DF and 8,173 SD cases met the eligibility criteria. A total of 64 factors were identified, including population and virus characteristics, clinical symptoms and signs, laboratory biomarkers, cytokines, and chemokines; of these factors, 34 were found to be significantly different between DF and SD, while the other 30 factors were not significantly different between the two groups after pooling the data from the relevant studies. Additionally, 9 factors were positive associated with SD within 7 days after illness when the timing subgroup analysis were performed.

Conclusions: Practical factors and biomarkers for the identification of SD were established, which will be helpful for a prompt diagnosis and early effective treatment for those at greatest risk. These outcomes also enhance our knowledge of the clinical manifestations and pathogenesis of SD.

Publication types

  • Meta-Analysis
  • Systematic Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers
  • Dengue* / diagnosis
  • Humans
  • Odds Ratio
  • Prognosis
  • Risk Factors
  • Severe Dengue* / diagnosis
  • Severe Dengue* / epidemiology

Substances

  • Biomarkers

Grants and funding

This work was funded by Guangzhou Science Technology and Innovation Committee (https://sop.gzsi.gov.cn/egrantweb/, NO. 201607010163 awards to Lidong Liu), Health and Family Planning Commission of Guangdong Province (http://wsjkw.gd.gov.cn/, NO. A2016448 awards to Lidong Liu) and Guangzhou Medical University (https://www.gzhmu.edu.cn/, NO.2014C24 awards to Lidong Liu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.